Edwards Lifesciences Corporation · EW
As of the latest run, Edwards Lifesciences Corporation (EW) scores 48/100 overall — a decent but mixed profile. Its strongest dimension: financial health (94/100); the one that most warrants attention: profitability (12/100).
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
Financial health comes in at 94/100 — a solid balance sheet, with controlled debt and sufficient liquidity. Growth comes in at 83/100 — sustained revenue growth. Valuation comes in at 62/100 — a reasonable price relative to the stock's own valuation history.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
Profitability falls to 12/100 — thin margins or a disappointing return on capital. The risk pillar falls to 16/100 — high volatility — the stock swings hard, both ways. Momentum falls to 23/100 — a deteriorated price trend.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.